<DOC>
	<DOCNO>NCT00413140</DOCNO>
	<brief_summary>Background Chronic airway inflammation present cystic fibrosis . Non-invasive inflammometry may useful disease management . Objective We study 1 ) ability fractional exhale nitric oxide inflammatory marker ( acidity , nitrite , nitrate , hydrogen peroxide , 8-isoprostane , interferon-γ , tumor necrosis factor-α , interleukin-2 , -4 , -5 , -10 ) exhale breath condensate , discriminate cystic fibrosis control child , , 2 ) relationship biomarkers control severity cystic fibrosis . Methods In 98 child ( 48 cystic fibrosis / 50 control ) , condensate collect use glass condenser . Exhaled nitric oxide measure use NIOX® .</brief_summary>
	<brief_title>Non-Invasive Biomarkers Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>CF population Children know CF recruit outpatient clinic . CF disease define combination typical clinical feature ( e.g . persistent pulmonary problem , meconium ileus , failure thrive , steatorrhoe ) abnormal sweat test ( Chloride &gt; 60 mM ) . Uncontrolled CF diagnose paediatric pulmonologist base change presence severity respiratory symptom association CF , and/or decrease lung function parameter compare previous measurement last four week . Control population Control child without lung disease recruit outpatient clinic University Hospital Maastricht . The reason consultation constipation enuresis nocturna . All child complete ‘ International Study Asthma Allergies Childhood ( ISAAC ) questionnaire exclude child ( history ) airway allergy complaint , order exclude asthmatic disease For study population : Diseases may interfere result study ( e.g . upper airway infection , heart disease , anatomic abnormality airways chronic inflammatory disease , Crohns disease rheumatoid arthritis ) Mental retardation Inability perform EBC collection procedure Active smoking Use follow medication : papaverin , sodium nitroprusside , angiotensinconverting enzyme ( ACE ) inhibitor , oxymetazoline , Larginine , nitric oxide synthase ( NOS ) inhibitor .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>November 2003</verification_date>
	<keyword>childhood disease</keyword>
	<keyword>cystic fibrosis</keyword>
	<keyword>exhale breath condensate</keyword>
	<keyword>exhale nitric oxide</keyword>
	<keyword>airway inflammation</keyword>
	<keyword>non-invasive inflammatory marker</keyword>
	<keyword>control</keyword>
	<keyword>child</keyword>
</DOC>